Most of area under the curve (AUC) values for CD13 at 1, 3, and 5 years were around or greater than 0.7 (Fig. 1E-H), which means that CD13 could be a relevant prognostic marker for glioma. The gene discussed is ANPEP; the disease is central nervous system cancer.